Freeline Therapeutics Holdings plc
NASDAQ:FRLN
6.49 (USD) • At close February 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -88.972 | -140.391 | -96.322 | -53.909 | -33.283 |
| Depreciation & Amortization
| 1.741 | 2.39 | 1.913 | 1.54 | 0.97 |
| Deferred Income Tax
| -0.156 | -0.171 | -0.158 | -4.558 | 0 |
| Stock Based Compensation
| 5.077 | 10.723 | 6.204 | 1.459 | 0.114 |
| Change In Working Capital
| 9.067 | 19.744 | -6.678 | -1.412 | 6.426 |
| Accounts Receivables
| 0 | 0.098 | -0.091 | 0 | 0.054 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 5.446 | -2.89 | 1.54 | 4.135 | 7.528 |
| Other Working Capital
| 3.621 | 22.536 | -8.127 | -5.547 | -1.156 |
| Other Non Cash Items
| -4.981 | 0.148 | 0.076 | 4.558 | 0 |
| Operating Cash Flow
| -78.224 | -107.557 | -94.965 | -52.322 | -25.773 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -7.014 | -4.274 | -2.514 | -3.022 | -3.749 |
| Acquisitions Net
| 0 | 0 | 0.127 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -0.001 | 0 | 0 |
| Investing Cash Flow
| -7.014 | -4.274 | -2.388 | -3.022 | -3.749 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 27.328 | 0.179 | 161.758 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.195 | -1.163 | 80.862 | 114.589 | 38.134 |
| Financing Cash Flow
| 27.523 | -0.984 | 242.62 | 114.589 | 38.134 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| -12.442 | 0.302 | 11.738 | -1.014 | -0.812 |
| Net Change In Cash
| -70.457 | -112.513 | 157.005 | 58.231 | 7.8 |
| Cash At End Of Period
| 48.606 | 119.063 | 231.576 | 74.571 | 16.34 |